Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis

Abstract

Condition tags

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (41)

• A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis via openalex
• Clinical dynamics of Dienogest for the treatment of endometriosis: from bench to bedside via openalex
• Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial via openalex
• Consensus on current management of endometriosis via openalex
• Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials via openalex
• Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study via openalex
• Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis via openalex
• Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β via openalex
• Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells via openalex
• Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study via openalex
• Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
• Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis via openalex
• Dienogest Versus Leuprolide Acetate for Recurrent Pelvic Pain Following Laparoscopic Treatment of Endometriosis via openalex
• Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model via openalex
• Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration via openalex
• Effects of long-term treatment with Dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain via openalex
• Effects of ranibizumab and zoledronic acid on endometriosis in a rat model via openalex
• Endometriosis via openalex
• Endometriosis: pathogenesis and treatment via openalex
• ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
• Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial via openalex
• Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study via openalex
• Exploratory study of pre-surgical medications with dienogest or leuprorelin in laparoscopic cystectomy of endometrial cysts via openalex
• Hormone treatment of endometriosis: the estrogen threshold hypothesis via openalex
• Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study via openalex
• Optimizing gonadotropin-releasing hormone agonist therapy in women with endometriosis via openalex
• Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women via openalex
• Pathogenesis and pathophysiology of endometriosis via openalex
• Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells via openalex
• Quality of life and sexual function of women affected by endometriosis-associated pelvic pain when treated with dienogest via openalex
• Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
• Rethinking mechanisms, diagnosis and management of endometriosis via openalex
• The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey via openalex
• Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials via openalex
• Women's experiences of endometriosis: a systematic review and synthesis of qualitative research via openalex
• W2012076119 via openalex
• W2079421112 via openalex
• W2166050085 via openalex
• W2021687464 via openalex
• W2996101359 via openalex
• W2101417341 via openalex

Cited by (4)

• Evaluation of the efficacy and tolerability of 4 mg dienogest in women with adenomyosis and BMI >30 2025
• Innovations in the diagnosis and treatment of endometriosis: from the current advancements to a future outlook: A review 2025
• The Efficacy of Medical Treatment on Endometrioma: A Systematic Review and Meta-Analysis 2024
• Efficacy and Safety of Dienogest in the Management of Women with Endometriosis; Systematic Review and Meta-Analysis 2023

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00